* Sees FY 2016 revenue $55 million to $60 million
Source text for Eikon:
Further company coverage:
The post BRIEF-Recro Pharma Q2 loss per share $0.83 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Sees FY 2016 revenue $55 million to $60 million
Source text for Eikon:
Further company coverage:
The post BRIEF-Recro Pharma Q2 loss per share $0.83 appeared first on NASDAQ.